SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is attracting significant investor attention ahead of its quarterly report, with the community actively debating whether the stock's recent valuation surge and strong revenue backlog will be enough to outweigh potential concerns regarding Neutron launch timelines and profitability. Traders are expressing mixed sentiment, with some highlighting high-conviction long-term growth prospects and new contract wins, while others are hedging with bearish positions due to sensitivity over earnings execution and market volatility.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is surging after signing a 20-year, $9.1 billion data center lease with Anthropic, a move the community views as a major strategic pivot toward AI infrastructure. While some investors remain skeptical of past management execution and potential volatility, many are bullish on the company's ability to monetize its power capacity as a key player in the AI buildout.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending as investors weigh strong subscriber and revenue growth against margin compression and ongoing regulatory scrutiny ahead of the upcoming earnings release. The community remains deeply divided, with bulls pointing to the company's aggressive international expansion and potential for AI-driven service integration, while bears highlight EPS misses and high acquisition costs as significant risks.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is seeing high engagement as investors weigh the company's long-term potential against concerns over quarterly financial performance and satellite launch execution. Community sentiment remains deeply divided, with bulls highlighting the massive $1.3B backlog and government contract wins while bears express skepticism regarding high cash burn and the consistency of the launch cadence.

Coherent Corp. engages in the development, refinement, manufacturing, and marketing of engineered materials, opto-electronic components and devices, and lasers for use in the industrial, communications, electronics, and instrumentation markets. It operates through the following segments: Networking, Materials, and Lasers. The Networking segment leverages compound semiconductor technology platforms and deep knowledge of end-user applications. The Materials segment markets engineered materials and optoelectronic devices. The Lasers segment serves industrial customers in semiconductor capital equipment, display capital equipment, precision manufacturing, and aerospace and defense, as well as instrumentation customers in life sciences and scientific research. The company was founded by Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

Coherent Corp

Coherent Corp is experiencing significant price volatility ahead of its upcoming earnings report, with the community divided between investors holding for long-term AI optical infrastructure growth and active traders attempting to navigate aggressive swings. The stock's recent pullback is being debated as either a healthy profit-taking reset within a structural AI bull cycle or a deeper technical warning signal.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is experiencing significant market volatility driven by institutional call flow and polarizing debates over its vehicle-market economics versus allegations of accounting irregularities. Investors are closely monitoring upcoming earnings and legal developments, as community sentiment remains deeply divided between those betting on a short squeeze and those convinced the stock is fundamentally overvalued.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending following the announcement of a strategic agreement to acquire Wisk Aero, SkyGrid, and Insitu from Boeing, a deal that integrates profitable defense revenue and advanced autonomous flight technology into Archer's operations. The community is actively debating the implications of this expansion, weighing the long-term potential of the diversified aerospace platform against concerns regarding share dilution and the company's ongoing capital requirements.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Markets are showing heightened volatility as investors weigh the Federal Reserve's interest rate path, persistent geopolitical tensions in the Middle East, and mixed corporate earnings results. The community is actively debating the sustainability of the AI sector's massive capital expenditure while closely monitoring labor data for clues on the potential for future policy shifts.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is currently trending due to a surge in positive sentiment and trading volume following the announcement of successful Phase 2 trial results for its lead asset, ABCL635. The community is actively discussing the stock's potential re-rating as a pharma-focused entity, with many investors highlighting strong analyst upgrades, significant institutional interest, and the perceived validation of the company's proprietary drug discovery platform.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is facing significant volatility as investors weigh the stock's recent decline against uncertainty surrounding the broader sports betting sector and upcoming quarterly earnings. While some community members remain bullish on the long-term potential of the company's new prediction markets and upcoming NFL season, others are actively debating the impact of increased competition and concerns over management's ability to drive consistent growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage

FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage FibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage PR Newswire HOUSTON, Aug. 5, 2026 Granted claims cover Sox9-based conversion of fibroblasts into...

FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate

FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate FibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate PR Newswire HOUSTON, July 31, 2026 - First...

FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors

FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors FibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors PR Newswire HOUSTON, July 9, 2026 Microbiologist, Retired NASA Astronaut, and Founding Director of the University of Pittsburgh Trivedi Institute...

FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial FibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial PR Newswire HOUSTON, July 7, 2026 Company...

FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference PR Newswire HOUSTON, June 30, 2026 HOUSTON, June 30, 2026 /PRNewswire...

FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules PR Newswire HOUSTON, June 29, 2026 $3.0 million upfront with up to...

FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules PR Newswire HOUSTON, June 26, 2026 $3.0 million upfront with up to approximately $6.0 million...

EXCLUSIVE: FibroBiologics Doses First Patients In Diabetic Foot Ulcers Clinical Trial

FibroBiologics Inc. (NASDAQ: FBLG) reports enrolling first patients in its Phase 1/2 trial for CYWC628, a fibroblast-based therapy targeting diabetic foot ulcers.read more...

Is FibroBiologics, Inc. (FBLG) Advancing Toward a Breakthrough Psoriasis Treatment With CYPS317 Data?

Is FibroBiologics, Inc. (FBLG) Advancing Toward a Breakthrough Psoriasis Treatment With CYPS317 Data...

EXCLUSIVE: FibroBiologics Targets 2026 Data Readout After Trial Progress For Diabetic Foot Ulcer Study

FibroBiologics releases CYWC628 batch for DFU trial, clears cGMP checks, prepares enrollment; interim data expected in Q3 2026.read more...

FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.

FibroBiologics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.63	--	--	N/A
Q2 '26	-$0.93	-$0.66	29.03%	BEAT
Q1 '26	-$1.31	--	--	N/A
Q4 '25	-$0.07	--	--	N/A
Q3 '25	-$0.12	-$0.13	-8.33%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q2 '26

Historical Earnings